SUBSCRIBE
SUBSCRIBE

Newly Tense Chinese Gobble Up Blood Pressure Drugs

October 11, 2006 | 
1 min read

SHANGHAI (Reuters) - Sales in China for drugs to treat hypertension are expected to nearly double to more than $800 million by 2010 as more Chinese are exposed to risk factors such as obesity, a U.S. research firm said.>>> Discuss This Story

Asia
Pfizer
MORE ON THIS TOPIC
Facade of AstraZeneca's office in Shanghai, China
Mergers & acquisitions
AstraZeneca Buys FibroGen’s China Unit for $160M as Probes Continue
February 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone business concept collage. Idea concept, business concept, financial planning,financial profit, favorable conditions, favorable conditions. Trendy modern retro illustration in bright trendy colors. Vector illustration
Mergers & acquisitions
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
February 10, 2025
 · 
1 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Rare diseases
AceLink’s Fabry Hopeful Shows Potential in Mid-Stage Study
February 10, 2025
 · 
2 min read
 · 
Tristan Manalac
vial of vaccine for the vaccination plan against diseases in the China. Doctor with a vial with doses of the vaccine in front of the China flag
Earnings
Merck’s Gardasil Woes Grow as China Trade War Heats Up
February 4, 2025
 · 
4 min read
 · 
Annalee Armstrong